|
Delayed
Hong Kong S.E.
02:37:17 2026-08-18 am EDT
|
5-day change | 1st Jan Change | ||
| 8.750 HKD | -0.06% |
|
+0.52% | +3.74% |
| Aug. 11 | CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus | MT |
| Aug. 10 | CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA | MT |
| Market Cap | 100B 12.76B 11.01B 10.33B 9.41B 17.7B 1,220B 17.94B 121B 47.47B 611B 47.9B 46.86B 2,033B | P/E 2026 * |
11.8x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 89.75B 11.44B 9.88B 9.27B 8.44B 15.87B 1,094B 16.09B 109B 42.56B 548B 42.95B 42.02B 1,823B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.48x |
| Free-Float |
67.42% | Yield 2026 * |
4.54% | Yield 2027 * | 4.17% |
| 1 day | -0.11% | ||
| 1 week | +0.52% | ||
| Current month | +1.92% | ||
| 1 month | +2.88% | ||
| 3 months | +15.37% | ||
| 6 months | -16.87% | ||
| Current year | +3.74% |
| 1 week | 8.52 |  | 9.22 |
| 1 month | 8.12 | | 9.22 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.61 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 2012-01-19 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 | Other | Director | -700,000 | 0.0061% | ||
| 12/23/25 | Other | Chairman | 6,706,000 | 0.0582% | ||
| 11/25/25 | Other | Chairman | 10,300,000 | 0.0894% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +0.52% | -19.92% | +54.78% | 12.76B | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,055B | |
| +0.78% | +0.21% | +48.53% | +50.78% | 632B | |
| +0.35% | +0.95% | +21.11% | +66.86% | 442B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 351B | |
| +0.78% | -2.68% | +24.03% | +37.32% | 290B | |
| +0.87% | -3.59% | -0.28% | +7.12% | 243B | |
| +1.00% | +0.52% | +41.46% | +58.95% | 227B | |
| -0.78% | -4.49% | -10.28% | -54.13% | 200B | |
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | |
| Average | +0.38% | -1.15% | +22.99% | +46.14% | 362.53B | |
| Weighted average by Cap. | +0.44% | -1.86% | +39.50% | +63.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.14B 4.61B 3.98B 3.73B 3.4B 6.39B 441B 6.48B 43.74B 17.14B 221B 17.3B 16.92B 734B | 35.13B 4.48B 3.87B 3.63B 3.3B 6.21B 428B 6.3B 42.51B 16.66B 214B 16.81B 16.45B 713B |
| Net income | 8.29B 1.06B 913M 856M 780M 1.47B 101B 1.49B 10.04B 3.93B 50.64B 3.97B 3.88B 168B | 6.84B 872M 753M 706M 643M 1.21B 83.41B 1.23B 8.28B 3.25B 41.79B 3.28B 3.2B 139B |
| Net Debt | -10.34B -1.32B -1.14B -1.07B -972M -1.83B -126B -1.85B -12.52B -4.9B -63.15B -4.95B -4.84B -210B | -13.09B -1.67B -1.44B -1.35B -1.23B -2.31B -160B -2.35B -15.84B -6.21B -79.91B -6.26B -6.13B -266B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | HK$8.750 | -0.06% | 35,845,310 |
| 26-08-17 | HK$8.755 | +0.75% | 70,421,131 |
| 26-08-14 | HK$8.690 | -1.81% | 39,418,434 |
| 26-08-13 | HK$8.850 | +2.02% | 105,733,552 |
| 26-08-12 | HK$8.675 | -0.29% | 50,923,111 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
